open access

Vol 6, No 1 (2021)
Letter to the Editor
Published online: 2021-02-25
Get Citation

Adverse reactions of COVID-19 vaccination: where do they come from?

Michal Pruc1, Aleksandra Gasecka23, Lukasz Szarpak45, Milosz J. Jaguszewski6, Krzysztof J. Filipiak2, Tomasz Dzieciatkowski7
DOI: 10.5603/DEMJ.a2021.0004
·
Disaster Emerg Med J 2021;6(1):48-49.
Affiliations
  1. Polish Society of Disaster Medicine, Warsaw, Poland
  2. First Chair and Department of Cardiology, Medical University of Warsaw, Poland
  3. Department of Cardiology, University Medical Center Utrecht, Netherlands
  4. Maria Sklodowska-Curie Medical Academy in Warsaw, Poland
  5. Maria Sklodowska-Curie Białystok Oncology Centre, Białystok, Poland
  6. 1st Department of Cardiology, Medical University of Gdansk, Poland
  7. Chair and Department of Medical Microbiology, Medical University of Warsaw, Poland

open access

Vol 6, No 1 (2021)
LETTERS TO THE EDITOR
Published online: 2021-02-25

Abstract

Not available

Abstract

Not available
Get Citation

Keywords

COVID-19, vaccinations, adverse reactions, polyethylene glycol, anaphylaxis

About this article
Title

Adverse reactions of COVID-19 vaccination: where do they come from?

Journal

Disaster and Emergency Medicine Journal

Issue

Vol 6, No 1 (2021)

Article type

Letter to the Editor

Pages

48-49

Published online

2021-02-25

DOI

10.5603/DEMJ.a2021.0004

Bibliographic record

Disaster Emerg Med J 2021;6(1):48-49.

Keywords

COVID-19
vaccinations
adverse reactions
polyethylene glycol
anaphylaxis

Authors

Michal Pruc
Aleksandra Gasecka
Lukasz Szarpak
Milosz J. Jaguszewski
Krzysztof J. Filipiak
Tomasz Dzieciatkowski

References (4)
  1. Baden LR, El Sahly HM, Essink B, et al. COVE Study Group. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021; 384(5): 403–416.
  2. Polack FP, Thomas SJ, Kitchin N, et al. C4591001 Clinical Trial Group. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020; 383(27): 2603–2615.
  3. CDC COVID-19 Response Team, Food and Drug Administration. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021. MMWR Morb Mortal Wkly Rep. 2021; 70(4): 125–129.
  4. Garvey LH, Nasser S. Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit? Br J Anaesth. 2021; 126(3): e106–e108.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl